Moneycontrol PRO
Access insightful & curated financial content with Moneycontrol PRO at just Re. 1/- per day. Use code PRO365.
you are here: HomeNewsBusiness

Dr. Reddy’s Laboratories Q1 PAT seen up 10.2% YoY to Rs 655.4 cr: KRChoksey

Net Sales are expected to increase by 19.1 percent Y-o-Y (up 10.5 percent Q-o-Q) to Rs 5,270.1 crore, according to KRChoksey.

July 13, 2021 / 11:37 AM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

KRChoksey has come out with its first quarter (April-June’ 21) earnings estimates for the Pharma sector. The brokerage house expects Dr. Reddy’s Laboratories to report net profit at Rs 655.4 crore up 10.2% year-on-year (up 17.3% quarter-on-quarter).


Net Sales are expected to increase by 19.1 percent Y-o-Y (up 10.5 percent Q-o-Q) to Rs 5,270.1 crore, according to KRChoksey.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 2 percent Y-o-Y (up 8.4 percent Q-o-Q) to Rs 1,143.6 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Close
Broker Research

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark